Evidence map›Paper›PMID 16633893›Full record

ArticleCellular and molecular neurobiology

Corticotropin Releasing Factor (CRF) activation of NF-kappaB-directed transcription in leukocytes.

Eric M Smith, Mike Gregg, Farhad Hashemi, Liesl Schott, Thomas K Hughes

Open access · greenAbstract readComparative Study
In one paragraph

Article in Cellular and molecular neurobiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
0.5field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. New epigenetic players in stroke pathogenesis: From non-coding RNAs to exosomal non-coding RNAs.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021
    Review
  9. Review
  10. Article
  11. Effect of Pregnane X Receptor onAnimals : an open access journal from MDPI · 2021
    Article
  12. Article
  13. Article
  14. Intermittent Ethanol Access Increases Sensitivity to Social Defeat Stress.Alcoholism, clinical and experimental research · 2020
    Article
  15. Review
  16. Article
  17. Review
  18. Cerebrovascular and Neurological Disorders: Protective Role of NRF2.International journal of molecular sciences · 2019
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Eric M SmithDepartment of Psychiatry and Behavioral Sciences, University of Texas Medical Branch, Galveston, Texas, USA. esmith@utmb.edu
Mike Gregg
Farhad Hashemi
Liesl Schott
Thomas K Hughes
The University of Texas Medical Branch at Galveston · USBaylor College of Medicine · US

Funding

Hypothalamic Pituitary Adrenal Axis Regulation by IL 10R01NS041495 · NINDS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI HUGHES, THOMAS K · 2001 to 2005
$1.7M
PIVOTAL REGULATOR IN NEURO-IMMUNE INTERACTIONSR01NS039974 · NINDS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI SMITH, ERIC M · 2000 to 2002
$807k
NINDS NIH HHS NS039974NINDS NIH HHS NS041495NINDS NIH HHS R01 NS041495
6 · The paper itself

Abstract

1. The aim of this study was to test whether CRF enhanced nuclear factor kappa B (NF-kappaB)-directed gene transcription in leukocytes and the receptor specificity of the effect. Initially, we examined the ability of CRF to modulate an antigen-specific, in vitro antibody response. Since that could be mediated by NF-kappaB transcription factor activity, we tested CRF in a NF-kappaB driven luciferase gene expression reporter assay. 2. CRF enhanced the antigen-specific antibody production in a dose- and time-dependent manner. RAW 264.7 macrophage cells and splenocytes stained by immunohistochemistry were positive for CRF receptors and CRF. Expression of both was up-regulated by mitogen treatment of the splenocytes. CRF also enhanced the NF-kappaB-regulated reporter assay and this could be blocked by a CRF-R1 receptor antagonist. 3. In light of these findings, it seems likely that CRF enhanced the antigen-specific antibody response through the CRF-R1 receptor by elevation of NF-kappaB activity. This study provides further support for the concept that CRF can act as an immunomodulator mediating neuro-immune interactions.

Indexed as

AnimalsCell ProliferationCells, CulturedCorticotropin-Releasing HormoneFemaleLeukocytesMiceMice, Inbred C57BLMice, KnockoutNF-kappa BSpleenTranscription, GeneticCorticotropin-Releasing HormoneNF-kappa B

Identifiers

PMID16633893
PMCPMC11520635
OpenAlexW2039220611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.